» Articles » PMID: 28919917

Anxiety but Not Depression is Associated with Metabolic Syndrome: The Isfahan Healthy Heart Program

Overview
Journal J Res Med Sci
Specialty General Medicine
Date 2017 Sep 19
PMID 28919917
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Only a few studies have carried out to evaluate the association of depression and anxiety with metabolic syndrome (MetS). The aim of this study was to investigate whether the depression and anxiety are associated with MetS and its different components.

Materials And Methods: This cross-sectional study forms part of the prospective Isfahan Cohort Study. A total of 470 participants were chosen. Anxiety and depression symptoms were measured using hospital anxiety and depression scale (HADS). The MetS was diagnosed according to the American Heart Association and National Heart, Lung, and Blood Institute. One-way analysis of variance and binary logistic regression were used.

Results: The mean age of participants was 55.7 ± 9.3. The prevalence of MetS in female participants with symptoms of depression ( < 0.0001), concurrent anxiety and depression ( = 0.004), anxiety ( < 0.0001), and asymptomatic individuals ( = 0.001) was significantly different when compared to male participants. Moreover, the analysis showed that having anxiety symptoms is in a negative relationship with MetS (odds ratio [OR] = 0.31; 95% confidence interval [CI] = 0.12-0.78). In addition, with each 10-year increase in age, the probability of MetS will decrease 40% (OR = 0.59; 95%Cl = 0.53-0.72). Body mass index (OR = 1.29; 95%CI = 1.21-1.37), and gender (higher age for women) (OR = 0.34; 95%CI = 0.11-0.98) had positive relationship with MetS.

Conclusion: The study findings revealed that the prevalence of MetS in patients with anxiety was lower than the healthy subjects, while no significant association was found between depression, concurrent depression, an anxiety with MetS.

Citing Articles

Development and validation of a predictive nomogram for the risk of MAFLD in postmenopausal women.

Yang M, Chen X, Shen Q, Xiong Z, Liu T, Leng Y Front Endocrinol (Lausanne). 2024; 15:1334924.

PMID: 39165508 PMC: 11334217. DOI: 10.3389/fendo.2024.1334924.


Association between anxiety and metabolic syndrome: An updated systematic review and meta-analysis.

Ji S, Chen Y, Zhou Y, Cao Y, Li X, Ding G Front Psychiatry. 2023; 14:1118836.

PMID: 36873213 PMC: 9978147. DOI: 10.3389/fpsyt.2023.1118836.


Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress.

Shea S, Lionis C, Kite C, Atkinson L, Chaggar S, Randeva H Biomedicines. 2021; 9(11).

PMID: 34829926 PMC: 8615558. DOI: 10.3390/biomedicines9111697.


The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety.

Zhong Y, Hu M, Wang Q, Yang Z, Zhu N, Wang F Sci Rep. 2021; 11(1):3324.

PMID: 33558554 PMC: 7870819. DOI: 10.1038/s41598-021-81653-2.


Association Between Cognitive Impairment and Blood Pressure Among Patients with Type II Diabetes Mellitus in Southern Iran.

Jamalnia S, Javanmardifard S, Akbari H, Sadeghi E, Bijani M Diabetes Metab Syndr Obes. 2020; 13:289-296.

PMID: 32104025 PMC: 7008183. DOI: 10.2147/DMSO.S238247.


References
1.
Hach I, Ruhl U, Klotsche J, Klose M, Jacobi F . Associations between waist circumference and depressive disorders. J Affect Disord. 2006; 92(2-3):305-8. DOI: 10.1016/j.jad.2006.01.023. View

2.
Kessler R, Berglund P, Demler O, Jin R, Merikangas K, Walters E . Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62(6):593-602. DOI: 10.1001/archpsyc.62.6.593. View

3.
Sarrafzadegan N, Kelishadi R, Esmaillzadeh A, Mohammadifard N, Rabiei K, Roohafza H . Do lifestyle interventions work in developing countries? Findings from the Isfahan Healthy Heart Program in the Islamic Republic of Iran. Bull World Health Organ. 2009; 87(1):39-50. PMC: 2649597. DOI: 10.2471/blt.07.049841. View

4.
Muhtz C, Zyriax B, Klahn T, Windler E, Otte C . Depressive symptoms and metabolic risk: effects of cortisol and gender. Psychoneuroendocrinology. 2009; 34(7):1004-11. DOI: 10.1016/j.psyneuen.2009.01.016. View

5.
Ho R, Niti M, Kua E, Ng T . Body mass index, waist circumference, waist-hip ratio and depressive symptoms in Chinese elderly: a population-based study. Int J Geriatr Psychiatry. 2007; 23(4):401-8. DOI: 10.1002/gps.1893. View